CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma.

Saved in:
Bibliographic Details
Title: CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma.
Authors: O'Steen, Shyril1 (AUTHOR) sosteen@fredhutch.org, Lee, Sang Y.1 (AUTHOR), Comstock, Melissa L.1 (AUTHOR), Kehret, Allie R.1 (AUTHOR), Lin, Yukang1 (AUTHOR), Hamlin, Donald K.2 (AUTHOR), Dexter, Shannon L.1 (AUTHOR), Hippe, Daniel S.3 (AUTHOR), Gooley, Ted A.3 (AUTHOR), Wilbur, D. Scott2 (AUTHOR), Li, Yawen2 (AUTHOR), Walter, Roland B.3,4 (AUTHOR), Till, Brian3,4 (AUTHOR), Orozco, Johnnie J.1,4 (AUTHOR), Green, Damian J.3,4 (AUTHOR) damiangreen@miami.edu
Source: Journal of Nuclear Medicine. May2026, Vol. 67 Issue 5, p693-699. 7p.
Database: Engineering Source
Full text is not displayed to guests.
Description
ISSN:01615505
DOI:10.2967/jnumed.125.270515